Stocks and Investing Stocks and Investing
Thu, October 5, 2023

Brian Tanquilut Maintained (CCRN) at Strong Buy with Decreased Target to $32 on, Oct 5th, 2023


Published on 2024-10-28 06:44:13 - WOPRAI, Brian Tanquilut
  Print publication without navigation


Brian Tanquilut of Jefferies, Maintained "Cross Country Healthcare, Inc." (CCRN) at Strong Buy with Decreased Target from $40 to $32 on, Oct 5th, 2023.

Brian has made no other calls on CCRN in the last 4 months.



There are 3 other peers that have a rating on CCRN. Out of the 3 peers that are also analyzing CCRN, 1 agrees with Brian's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jonathan Yong of "Credit Suisse" Maintained at Hold with Decreased Target to $26 on, Tuesday, August 8th, 2023


These are the ratings of the 2 analyists that currently disagree with Brian


  • Kevin Steinke of "Barrington Research" Maintained at Buy with Decreased Target to $29 on, Monday, August 14th, 2023
  • Trevor Romeo of "William Blair" Initiated at Buy on, Monday, June 26th, 2023
Contributing Sources